Shih‐Chen Tung

4.0k total citations
23 papers, 351 citations indexed

About

Shih‐Chen Tung is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shih‐Chen Tung has authored 23 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shih‐Chen Tung's work include Thyroid Cancer Diagnosis and Treatment (5 papers), Thyroid Disorders and Treatments (4 papers) and Pituitary Gland Disorders and Treatments (4 papers). Shih‐Chen Tung is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (5 papers), Thyroid Disorders and Treatments (4 papers) and Pituitary Gland Disorders and Treatments (4 papers). Shih‐Chen Tung collaborates with scholars based in Taiwan, United States and Canada. Shih‐Chen Tung's co-authors include Ming‐Chun Kuo, Pei‐Wen Wang, Jung‐Fu Chen, Ching‐Jung Hsieh, Rue‐Tsuan Liu, Shan‐Tair Wang, I.-Yueh Huang, Ya‐Hui Hu, Yohsuke Taira and Vincenzo Panagia and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Metabolism.

In The Last Decade

Shih‐Chen Tung

23 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Chen Tung Taiwan 11 245 119 53 50 39 23 351
Hamıyet Yilmaz Türkiye 11 199 0.8× 89 0.7× 44 0.8× 37 0.7× 48 1.2× 27 354
Richard E. Pratley United States 7 240 1.0× 79 0.7× 79 1.5× 52 1.0× 55 1.4× 10 332
Guoyu Tong China 9 231 0.9× 93 0.8× 117 2.2× 120 2.4× 33 0.8× 10 336
Richard Cosgrove United States 7 130 0.5× 85 0.7× 96 1.8× 40 0.8× 47 1.2× 12 311
Aki Ikoma Japan 9 135 0.6× 60 0.5× 68 1.3× 79 1.6× 17 0.4× 23 308
Sau-Cheung Tiu China 7 172 0.7× 139 1.2× 55 1.0× 40 0.8× 8 0.2× 7 298
Wenying Huang United States 5 222 0.9× 78 0.7× 171 3.2× 46 0.9× 57 1.5× 9 362
Kazuyuki Namai Japan 10 93 0.4× 115 1.0× 34 0.6× 85 1.7× 10 0.3× 15 278
Sinan Tanyolaç Türkiye 7 100 0.4× 45 0.4× 97 1.8× 48 1.0× 18 0.5× 11 264
Aditya Goud United States 9 169 0.7× 109 0.9× 110 2.1× 20 0.4× 42 1.1× 24 332

Countries citing papers authored by Shih‐Chen Tung

Since Specialization
Citations

This map shows the geographic impact of Shih‐Chen Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Chen Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Chen Tung more than expected).

Fields of papers citing papers by Shih‐Chen Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Chen Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Chen Tung. The network helps show where Shih‐Chen Tung may publish in the future.

Co-authorship network of co-authors of Shih‐Chen Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Chen Tung. A scholar is included among the top collaborators of Shih‐Chen Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Chen Tung. Shih‐Chen Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Pei‐Wen, Shih‐Chen Tung, Ming‐Chun Kuo, et al.. (2020). Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy. Journal of Diabetes Investigation. 11(4). 923–929. 4 indexed citations
2.
Yang, Yiting, Jung‐Fu Chen, Shih‐Chen Tung, et al.. (2020). Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease. Journal of the Formosan Medical Association. 119(5). 925–932. 4 indexed citations
3.
Chen, Jung‐Fu, et al.. (2016). Impact of baseline body mass index status on glucose lowering and weight change during sitagliptin treatment for type 2 diabetics. Diabetes Research and Clinical Practice. 120. 8–14. 6 indexed citations
4.
Hsieh, Ching‐Jung, et al.. (2012). Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 98(2). 257–263. 22 indexed citations
5.
Wang, Pei-Wen, et al.. (2012). The Influence of Self-monitoring Blood Glucose Frequency on the Oscillation of Hemoglobin A1c and Chronic Complications. Biomedical Journal. 35(1). 46–46. 15 indexed citations
6.
7.
Huang, I.-Yueh, Rue‐Tsuan Liu, Shih‐Chen Tung, et al.. (2011). Long‐term outcomes of distant metastasis from differentiated thyroid carcinoma. Clinical Endocrinology. 76(3). 439–447. 56 indexed citations
8.
Tung, Shih‐Chen, et al.. (2009). Remission of Cushing Syndrome in a Patient With Primary Pigmented Nodular Adrenocortical Disease With Unilateral Adrenalectomy. The Endocrinologist. 19(2). 75–78. 2 indexed citations
9.
Huang, Shu‐Hua, Pei‐Wen Wang, Fong‐Fu Chou, et al.. (2006). Sequential Follow-up of Serum Thyroglobulin and Whole Body Scan in Thyroid Cancer Patients without Initial Metastasis. Thyroid. 16(12). 1273–1278. 19 indexed citations
10.
Tung, Shih‐Chen, Pei‐Wen Wang, Tung‐Liang Huang, Joseph W. Yang, & Wei J. Chen. (2005). Carney Complex With Primary Pigmented Nodular Adrenocortical Disease and Bilateral Papillary Thyroid Carcinoma Occurring 11 Years Apart. The Endocrinologist. 15(4). 243–247. 5 indexed citations
11.
12.
Chen, Jung‐Fu, Rue‐Tsuan Liu, Shih‐Chen Tung, et al.. (2004). Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.. PubMed. 103(6). 442–7. 23 indexed citations
13.
Hsieh, Ching‐Jung, Pei‐Wen Wang, Rue‐Tsuan Liu, et al.. (2004). Orlistat for obesity: benefits beyond weight loss. Diabetes Research and Clinical Practice. 67(1). 78–83. 52 indexed citations
14.
Hsieh, Ching‐Jung, Pei‐Wen Wang, Shan‐Tair Wang, et al.. (2002). Serum leptin concentrations of patients with sequential thyroid function changes. Clinical Endocrinology. 57(1). 29–34. 31 indexed citations
15.
Wang, Pei-Wen, Chia‐Wei Liou, Shan‐Tair Wang, et al.. (2002). Relative impact of low-density lipoprotein-cholesterol concentration and insulin resistance on carotid wall thickening in nondiabetic, normotensive volunteers. Metabolism. 51(2). 255–259. 12 indexed citations
16.
Wang, Pei‐Wen, et al.. (1999). Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma1. The Journal of Clinical Endocrinology & Metabolism. 84(12). 4549–4553. 33 indexed citations
17.
Tung, Shih‐Chen, et al.. (1996). Ectopic parathyroid adenoma with severe hungry bone syndrome: a case report.. PubMed. 19(2). 196–202. 2 indexed citations
18.
Tung, Shih‐Chen, et al.. (1996). The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report.. PubMed. 19(4). 358–63. 2 indexed citations
19.
Wang, Pei‐Wen, et al.. (1994). Tc-99m Pertechnetate Trapping and Thyroid Function in Hashimotoʼs Thyroiditis. Clinical Nuclear Medicine. 19(3). 177–180. 5 indexed citations
20.
Panagia, Vincenzo, Yohsuke Taira, P. K. Ganguly, Shih‐Chen Tung, & Naranjan S. Dhalla. (1990). Alterations in phospholipid N-methylation of cardiac subcellular membranes due to experimentally induced diabetes in rats.. Journal of Clinical Investigation. 86(3). 777–784. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamıyet Yilmaz Breakdown of academic impact, for papers by Richard E. Pratley Breakdown of academic impact, for papers by Guoyu Tong Breakdown of academic impact, for papers by Richard Cosgrove Breakdown of academic impact, for papers by Aki Ikoma Breakdown of academic impact, for papers by Sau-Cheung Tiu Breakdown of academic impact, for papers by Wenying Huang Breakdown of academic impact, for papers by Kazuyuki Namai Breakdown of academic impact, for papers by Sinan Tanyolaç Breakdown of academic impact, for papers by Aditya Goud
Rankless by CCL
2026